Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Fatty Acid Oxidation Disorders (FAODs) Market Growth in 2025?

The market for fatty acid oxidation disorders (FAODs) has witnessed significant expansion in the past few years. The market is projected to escalate from $9.55 billion in 2024 to $10.33 billion in 2025, with a compound annual growth rate (CAGR) of 8.1%. The upsurge during the historical period can be credited to heightened awareness, an increase in the occurrence of rare and hereditary disorders, a rise in the number of approved products, an upswing in government initiatives, and a boosted demand for orphan drugs.

What Is the Forecast for the Fatty Acid Oxidation Disorders (FAODs) Market Size Through 2029?

The market for fatty acid oxidation disorders (FAODs) is anticipated to experience substantial growth in the coming years, increasing to $13.99 billion by 2029 with a compound annual growth rate (CAGR) of 7.9%. Major contributing factors to this predicted growth are the escalated demand for eco-friendly bio-products, the rise in individualized medicine, early detection of FAODS, augmented funding for research and development activities, and the emphasis on improving long-term patient outcomes. Upcoming trends during this forecast period encompass the incorporation of telehealth services, the application of artificial intelligence in diagnostics and drug discovery, breakthroughs in genetic testing, technological advancements, and a shift towards more patient-focused care models.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21964&type=smp

What are the Key Market Players in Fatty Acid Oxidation Disorders (FAODs) Market and How They’re Evolving?

Major companies operating in the fatty acid oxidation disorders (FAODs) market are BASF SE, Thermo Fisher Scientific Inc, Takeda Pharmaceutical Company Limited, Baxter International Inc, Koninklijke DSM NV, Ingredion Incorporated, Lonza Group Ltd, Roquette Frères SA, Dr Reddy’s Laboratories Limited, Tate & Lyle PLC, ANI Pharmaceuticals Inc, Ultragenyx Pharmaceutical Inc, Gulshan Polyols Limited, Hubei Guangji Pharmaceutical Co Ltd, Omega Laboratories Limited, Actiza Pharmaceutical Private Limited, Allmpus Laboratories Private Limited, Reneo Pharmaceuticals Inc, Greenwell Lifesciences, NB Group Co Ltd.

What Are the Primary Growth Drivers in the Fatty Acid Oxidation Disorders (FAODs) Market?

The escalating need for gene therapy is predicted to accelerate the expansion of the fatty acid oxidation disorders (FAODs) market. Gene therapy is a medical approach that involves modifying or substituting faulty genes to cure or thwart diseases. The surge in demand for this therapy stems from its capability to treat genetic disorders, cancer, and uncommon diseases by tackling the root genetic causes. This potential has resulted in considerable investments and progress in biotechnology. Gene therapy aims to rectify metabolic insufficiencies provoked by FAODs by introducing functional genes, reviving enzymatic activity, boosting energy generation, and averting disease complexities. For example, in April 2024, the American Society of Gene & Cell Therapy, a US-based institution for gene and cell therapy, reported a 10% increase in gene therapies in Phase III clinical trials in the last quarter. This marked the inaugural growth of this sort since the third quarter in 2022. As a result, the burgeoning demand for gene therapy is fuelling the growth of the FAODs market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=21964&type=smp

What Are the Leading Segments in the Global Fatty Acid Oxidation Disorders (FAODs) Industry?

The fatty acid oxidation disorders (FAODs) market covered in this report is segmented –

1) By Type: Long Chain, Short Chain

2) By Drug Type: Levocarnitine, Dextrose, Riboflavin, Other Drug Types

3) By Route of Administration: Oral, Intravenous

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Stores

5) By End User: Hospitals, Clinics, Pharmaceutical Companies

Subsegments:

1) By Long Chain: Very Long-Chain Acyl-CoA Dehydrogenase Deficiency (VLCAD), Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency (LCHAD), Trifunctional Protein Deficiency (TFP), Carnitine Palmitoyltransferase II Deficiency (CPT II)

2) By Short Chain: Medium-Chain Acyl-CoA Dehydrogenase Deficiency (MCAD), Short-Chain Acyl-CoA Dehydrogenase Deficiency (SCAD), Carnitine Uptake Defect (CUD)

What Are the Key Market Trends in the Fatty Acid Oxidation Disorders (FAODs) Industry?

Leading businesses within the fatty acid oxidation disorders (FAODs) market are honing their focus on the production of innovative solutions, such as peroxisome proliferator-activated receptor delta (PPARd) agonists, to bolster metabolic control and improve patient results. PPARd agonists activate the PPARd receptor, which has a role in managing lipid metabolism, inflammation, and energy equilibrium, and could potentially offer treatment benefits for metabolic disorders and heart-related diseases. For example, in January 2023, Reneo Pharmaceuticals Inc., a clinical-stage pharmaceutical company based in the US, was granted Fast Track designation by the U.S. Food and Drug Administration (FDA) for its experimental drug, Mavodelpar (REN001). This drug targets long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency, a genotype related to long-chain fatty acid oxidation disorder (LC-FAOD). The aim of Mavodelpar, by activating PPARd, is to boost mitochondrial function, enhance energy metabolism, and alleviate symptoms linked with LC-FAOD.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/fatty-acid-oxidation-disorders-faods-global-market-report

What Is the Regional Outlook for the Fatty Acid Oxidation Disorders (FAODs) Market?

Asia-Pacific was the largest region in the fatty acid oxidation disorders (FAODs) market in 2024. The regions covered in the fatty acid oxidation disorders (FAODs) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21964

This Report Delivers Insight On:

1. How big is the fatty acid oxidation disorders (faods) market, and how is it changing globally?

2. Who are the major companies in the fatty acid oxidation disorders (faods) market, and how are they performing?

3. What are the key opportunities and risks in the fatty acid oxidation disorders (faods) market right now?

4. Which products or customer segments are growing the most in the fatty acid oxidation disorders (faods) market?

5. What factors are helping or slowing down the growth of the fatty acid oxidation disorders (faods) market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model